Meeder Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Meeder Asset Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-68	Closed	-$1K	–	2213
2021 Q3	$1K	Buy	68 +62	+1,033%	+$1.04K	﹤0.01%	2374
2021 Q2	$0	Sell	6 -920	-99%	-$15.7K	﹤0.01%	2653
2021 Q1	$17K	Buy	926 +901	+3,604%	+$16.2K	﹤0.01%	1465
2020 Q4	$0	Sell	25 -4	-14%	-$70	﹤0.01%	2204
2020 Q3	$1K	Buy	+29	New	+$528	﹤0.01%	2052
2020 Q2	–	Sell	-191	Closed	-$3K	–	2451
2020 Q1	$3K	Hold	191	–	–	﹤0.01%	1998
2019 Q4	$4K	Hold	191	–	–	﹤0.01%	1863
2019 Q3	$3K	Hold	191	–	–	﹤0.01%	1896
2019 Q2	$3K	Buy	+191	New	+$3.48K	﹤0.01%	1812

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BCP

BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Meeder Asset Management's TAK Position: Q4 2021 in Review

Meeder Asset Management sold out of Takeda Pharmaceutical (TAK) in Q4 2021, closing a stake of 68 shares — an estimated $1K sold.

Meeder Asset Management first reported a position in TAK in Q2 2019 and held it in 9 quarters. The position peaked at $17K in Q1 2021. 298 funds tracked by Wall St. Rank hold TAK as of Q4 2021.

Meeder Asset Management reported no remaining Takeda Pharmaceutical position as of Q4 2021 after selling out during the quarter.
Meeder Asset Management sold 68 Takeda Pharmaceutical shares in Q4 2021, an estimated $1K.
Meeder Asset Management first reported a position in Takeda Pharmaceutical in Q2 2019 and held it in 9 quarters.
Meeder Asset Management's Takeda Pharmaceutical position peaked at $17K in Q1 2021.
298 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2021.

Based on Meeder Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.